Impact on pulmonary, cardiac, and renal function and long-term quality of life after hospitalization for acute respiratory distress syndrome due to COVID-19: Protocol of the Post-COVID Brazil 3 study
Authors:
- Fernando Luís ScolariFSFernando Luís Scolari
- Marciane Maria RoverMRMarciane Maria Rover
- Geraldine TrottGTGeraldine Trott
- Mariana Motta Dias da SilvaMSMariana Motta Dias da Silva
- Raine Fogliati de Carli SchardosimRSRaine Fogliati de Carli Schardosim
- Rosa da Rosa Minho dos SantosRSRosa da Rosa Minho dos Santos
- Emelyn de Souza RoldãoEREmelyn de Souza Roldão
- Duane MocellinDMDuane Mocellin
- Jennifer Menna Barreto de SouzaJSJennifer Menna Barreto de Souza
- Aline Paula MiozzoAMAline Paula Miozzo
- Gabriela Soares RechGRGabriela Soares Rech
Open Access
- 1 January 2024
- journal article
- research article
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 36
Abstract
Rationale: Evidence about long-term sequelae after hospitalization for acute respiratory distress syndrome due to COVID-19 is still scarce. Purpose: To evaluate changes in pulmonary, cardiac, and renal function and in quality of life after hospitalization for acute respiratory distress syndrome secondary to COVID-19. Methods: This will be a multicenter case–control study of 220 participants. Eligible are patients who are hospitalized for acute respiratory distress syndrome due to COVID-19. In the control group, individuals with no history of hospitalization in the last 12 months or long-term symptoms of COVID-19 will be selected. All individuals will be subjected to pulmonary spirometry with a carbon monoxide diffusion test, chest tomography, cardiac and renal magnetic resonance imaging with gadolinium, ergospirometry, serum and urinary creatinine, total protein, and urinary microalbuminuria, in addition to quality-of-life questionnaires. Patients will be evaluated 12 months after hospital discharge, and controls will be evaluated within 90 days of inclusion in the study. For all the statistical analyses, p < 0.05 is the threshold for significance. Results: The primary outcome of the study will be the pulmonary diffusing capacity for carbon monoxide measured after 12 months. The other parameters of pulmonary, cardiac, and renal function and quality of life are secondary outcomes. Conclusion: This study aims to determine the long-term sequelae of pulmonary, cardiac, and renal function and the quality of life of patients hospitalized for acute respiratory distress syndrome due to COVID-19 in the Brazilian population.Keywords
This publication has 26 references indexed in Scilit:
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated CardiomyopathyJACC: Heart Failure, 2017
- Brazilian Valuation of EQ-5D-3L Health StatesMedical Decision Making, 2015
- The minimum clinically important difference for EQ-5D index: a critical reviewExpert Review of Pharmacoeconomics & Outcomes Research, 2014
- Development, validity, and reliability of the General Activities of Daily Living Scale: a multidimensional measure of activities of daily living for older peopleBrazilian Journal of Psychiatry, 2014
- SARC-F: A Simple Questionnaire to Rapidly Diagnose SarcopeniaJournal of the American Medical Directors Association, 2013
- Acute Respiratory Distress SyndromeJAMA, 2012
- Functional Disability 5 Years after Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2011
- One-Year Outcomes in Survivors of the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2003
- Evaluation of Clinical Methods for Rating DyspneaChest, 1988